Skip to content
OpenCapital
Get started

Idexx Laboratories IDXX CAG Diagnostics capital - instruments — Total Revenue

Other product segments

IDEXX VetLab consumables
$412.58M+19.7%
Reference laboratory diagnostic and consulting services
$386.18M+12.1%
Rapid assay products
$84.94M+1.1%
Recurring revenue
$73.54M+11.8%
CAG Diagnostics services and accessories
$36.61M+10.8%
Systems and hardware
$17.75M+12.5%

Similar metrics at other companies

Zoetis logo
ZTSAnimal health diagnostics — Revenue
$117M+12.5%
TEC
TECHInstruments — Revenue
$27.66M+5.9%
Labcorp Holdings logo
LHDiagnostics — Revenue
$2.76B+5.0%
Thermo Fisher Scientific logo
TMOInstruments — Consolidated revenues
$1.56B-4.4%
GeneDx Holdings logo
WGSDiagnostic Test — Total Revenue
$101.3M+18.1%
Liquidity Services logo
LQDTCAG — Revenue
$10.78M+12.3%

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$43.5B+2.0%
Enterprise value$43.88B+1.7%
P/E39.7×-3.6×
P/S9.8×-0.8×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's cag diagnostics capital - instruments — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's CAG diagnostics capital - instruments — total revenue?
Idexx Laboratories (IDXX) reported CAG diagnostics capital - instruments — total revenue of $42.45M in Q1 2026.
How has Idexx Laboratories's CAG diagnostics capital - instruments — total revenue changed year-over-year?
Idexx Laboratories's CAG diagnostics capital - instruments — total revenue increased by 32.7% year-over-year, from $31.99M to $42.45M.
What is the long-term trend for Idexx Laboratories's CAG diagnostics capital - instruments — total revenue?
Over 4 years (2021 to 2025), Idexx Laboratories's CAG diagnostics capital - instruments — total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $149.14M to $200.21M.
What does CAG diagnostics capital - instruments — total revenue mean?
This metric represents the total revenue generated from the sale and lease of diagnostic capital equipment, specifically benchtop chemistry and hematology analyzers, within the Companion Animal Group (CAG) segment. These instruments serve as the foundational hardware platform that drives recurring revenue through the subsequent sale of proprietary, single-use diagnostic test consumables. Growth in this metric indicates successful market penetration and the expansion of the installed base of diagnostic hardware in veterinary practices.